GLAND PHARMA is gearing to break a 3 year resistance and has created a 1 Year Cup and handle and retesting levels after a prolonged downslide over 3 years. Volume and RSI are high.
The information on this site is for educational purposes only and is not investment/trading advice/research and may be delayed. Please do your own research before making any investment decisions. The Materials on Site are provided on an 'as is' basis. The data feed for the website is sourced and curated using automated algorithms from various data sources. The...
BUY - GLAND PHARMA LTD
CMP - Rs. 1617
Target - 1: Rs. 2184
Target - 2: Rs. 2773
Target - 3: Rs. 3504
.
Here's the link to the previous chart -
.
Timeframe - 4 months - 18 months
.
Technicals - Trendline Breakout
.
This is just a view by an expert analyst, please invest at your own risk.
.
Follow me for more!
BUY - GLAND PHARMA LTD
CMP - Rs. 935
Target - 1: Rs. 1360
Target - 2: Rs. 1700
.
.
Technicals - Gap Down
.
This is just a view by an expert analyst, please invest at your own risk.
.
Follow me for more!
Gland Pharma freezes at 20% upper circuit on strong June quarter show
The firm's gross profit margin was up 700 bp year-on-year (YoY) to 63 per cent for Q1 due to lower raw material costs. On a sequential basis, gross profit margin improved by 900 bp from 54 per cent
Shares of Gland Pharma were locked in the 20 per cent upper circuit at Rs 1,612.60 on the BSE in...
Gland pharma made nearly a perfect bottom here. Huge volume spike at the bottom and multiple divergences on weekly RSI and MACD. Made a higher high with a 20% upper circuit today. Entire pharma sector is outperforming. Its one of the most lagging stock in pharma sector. Still down almost 63% from ATH. Its a very good buy for long term.
GLAND
Red is 20EMA
Market Broke above Swing High
Entry-980
SL-950
TGT-1-1190
TGT-2-1450
R:R-1:65
*EXIT METHOD*
1ST TGT With SL (50%)
(50%) Wait for 2ND TGT With SL Cost to Cost or Trail
*Entry Tips*
*Aggressive traders can consider buying above the high of the breakout candle.
*Safe traders wait for a retest of the breakout level and then enter a buy...
After very long down trend pharma sector is showing sign.
A short term uptrend in Gland pharma is possible which can take prices to 1720.
Considering recent quick up move risk (SL) become high. So waiting for some cool off in price will be good idea before purchasing.
Gland Pharma tanks 20%, hits record low on weak Q4 results
Revenue declined 29% YoY due to lower offtake of the key products in developed as well as domestic markets and due to Production line shut down in Pashamylaram Penems facility due to line upgradation.
This an entry regarding a positional trade on Gland Pharma. The stock after a long and sharp down trend is attempting to reverse. Significant volume action is visible. Here we analyze the price and volume action.
Gland Pharma Cmp 1417 dated 19-4-2023
1. Rectangle Consolidation BO @ 1415
2. Price Rise with Volume Rise
3. RSI BO
Buy above 1425 & @ dips till 1350 for target 1480-
1520-1615-1660 SL 1300
It is just a view, pls trade at your own risk.
Based on the chart analysis, it appears that the stock is reaching a potential bottom point. This is indicated by a bullish divergence pattern at the all-time low, which typically suggests a possible reversal of the downward trend. Additionally, the stock has recently broken through a short-term resistance trendline, indicating a possible upward...
